SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$1.04
-0.05 (-5.02%)
▼
5d:
+2.97%
30d:
-9.57%
90d:
-15.45%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 07, 2026
3d
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SBFM trading at deep discount. Market pricing in -5.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SBFM trading at deep discount. Market pricing in -5.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.71
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.06
2.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $1.04, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.1) compared to its historical average (3.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBFM is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.10. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: SBFM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+573.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBFM is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.10. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: SBFM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+573.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.04 -
$1.17
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 573.1% below Wall St target ($7.00)
Fair Price Analysis
30-Day Fair Range
$1.04 -
$1.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.10
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.15
Wall Street Target
$7.00
(+573.1%)
Revenue Growth (YoY)
1.2%
Profit Margin
-17.3%
Valuation Discount vs History
-5.3% cheaper
PE vs Historical
3.2 vs 3.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.3%
(market-implied from PE analysis)
1-Year Target
$0.98
(-5%)
2-Year Target
$0.93
(-10%)
3-Year Target
$0.88
(-15%)
3-Yr Target (if PE normalizes)
(PE: 3→4)
$1.04
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.2 to 3.7
Stabilization Target:
$1.22
(+17.4%)
PE Expansion Potential:
+17.4%
Share & Embed Analysis
Last updated: April 02, 2026 7:11 PM ET
Data refreshes hourly during market hours. Next update: 8:11 PM
Data refreshes hourly during market hours. Next update: 8:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 63 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 56 HOLD |
